Full Year 2025 Smith & Nephew PLC Earnings Call Transcript
Key Points
- Smith & Nephew PLC (SNN) reported a strong finish to 2025, achieving results at the high end of their guidance for revenue growth, margin, and free cash flow.
- The company achieved underlying revenue growth of 5.3% for the full year, with all three business units growing by over 5%.
- Innovation is a key driver, with over 60% of growth in 2025 coming from products launched in the last five years, delivering double-digit growth across all business units.
- Smith & Nephew PLC (SNN) expanded its trading margin by 160 basis points, driven by cost savings and improvements in the orthopedics business.
- Free cash flow increased by 52.5% year-on-year to $840 million, enabling the completion of a $500 million share buyback program.
- The company faced significant headwinds from VBP in China, FX volatility, and higher inflation, impacting their margins.
- Despite improvements, the US knee business still requires more work to close the gap with market growth.
- The acquisition of Integrity Orthopedics is expected to be dilutive to trading profit in 2026, with accretive benefits not expected until 2028.
- Smith & Nephew PLC (SNN) anticipates a 15 to 20 million reduction in profit from China due to VBP impacts on AET and ENT.
- The company faces extraordinary headwinds in 2026, including tariffs and changes to reimbursement in the US AWM business, which could impact profitability.
Good morning. Welcome to the Smith and Nephew Q4 in full year '25 results presentation. I'm Deepak Nath. I'm the Chief Executive Officer and joining me is
For the full year, underlying revenue growth of 5.3%, and importantly, all three of our business units grew by over 5%. Sports medicine and ENT and in particular joint repair within that had another strong year. And in orthopedics, we saw meaningful progress.
You know US recon business, particularly hips and in trauma, or there's more work to do in US knees or O US business, knees business has
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
